CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15% equity shareholding of Biocon Biologics by Serum Institute Life Sciences https://www.taxtmi.com/news?id=25423 CCI approves a merger by absorption in which Covidshield Technologies Private Limited, a wholly owned subsidiary of Serum Institute Life Sciences, will be merged into Biocon Biologics Limited, and the Acquirer will receive an equity stake in the Target on a fully diluted basis; detailed order to follow. en-us Thu, 19 May 2022 14:07:21 +0530 Thu, 19 May 2022 14:07:21 +0530 TaxTMI RSS Generator CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15% equity shareholding of Biocon Biologics by Serum Institute Life Sciences https://www.taxtmi.com/news?id=25423 CCI approves a merger by absorption in which Covidshield Technologies Private Limited, a wholly owned subsidiary of Serum Institute Life Sciences, will be merged into Biocon Biologics Limited, and the Acquirer will receive an equity stake in the Target on a fully diluted basis; detailed order to follow. News - Thu, 19 May 2022 14:07:21 +0530 https://www.taxtmi.com/news?id=25423